Introduction GenEros BioPharma LTD was founded in January 2018, is located in Hangzhou, Zhejiang, China, the first registered capital of 15.56 million yuan. Founded on the original discovery of JAK-STAT signaling pathway by founder Professor Fu Xinyuan and his team and the important regulatory function of Th-GM cell subtypes in human diseases, the company is an innovation-driven biomedical company dedicated to the precision treatment of autoimmune diseases and various inflammatory diseases.
GenEros BioPharma LTD has a series of core intellectual property rights based on JAK-STAT and the original Th-GM signaling pathway principles, and on this basis has developed a series of breakthrough protocols and targeted drugs for the accurate detection and treatment of various indications such as autoimmune diseases, major inflammatory diseases, tumors, and other diseases such as Alzheimer's disease. |